BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35570947)

  • 1. AI-Enabled Opportunities and Transformation Challenges for SMEs in the Post-pandemic Era: A Review and Research Agenda.
    Lu X; Wijayaratna K; Huang Y; Qiu A
    Front Public Health; 2022; 10():885067. PubMed ID: 35570947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the COVID-19 pandemic on the adoption and impact of AI ChatGPT: Challenges, applications, and ethical considerations.
    Hussain T; Wang D; Li B
    Acta Psychol (Amst); 2024 Jun; 246():104264. PubMed ID: 38626597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telehealth interventions during COVID-19 pandemic: a scoping review of applications, challenges, privacy and security issues.
    Tukur M; Saad G; AlShagathrh FM; Househ M; Agus M
    BMJ Health Care Inform; 2023 Aug; 30(1):. PubMed ID: 37541739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Review of the Technological Solutions to Analyse the Effects of Pandemic Outbreak on Human Lives.
    Shah I; Doshi C; Patel M; Tanwar S; Hong WC; Sharma R
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital imaging, technologies and artificial intelligence applications during COVID-19 pandemic.
    Alhasan M; Hasaneen M
    Comput Med Imaging Graph; 2021 Jul; 91():101933. PubMed ID: 34082281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities and Challenges for Construction Health and Safety Technologies under the COVID-19 Pandemic in Chinese Construction Projects.
    Yang Y; Chan APC; Shan M; Gao R; Bao F; Lyu S; Zhang Q; Guan J
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Study of Artificial Intelligence and Machine Learning Approaches in Confronting the Coronavirus (COVID-19) Pandemic.
    Rahman MM; Khatun F; Uzzaman A; Sami SI; Bhuiyan MA; Kiong TS
    Int J Health Serv; 2021 Oct; 51(4):446-461. PubMed ID: 33999732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Big Data and Artificial Intelligence in COVID-19 Prevention, Diagnosis, Treatment and Management Decisions in China.
    Dong J; Wu H; Zhou D; Li K; Zhang Y; Ji H; Tong Z; Lou S; Liu Z
    J Med Syst; 2021 Jul; 45(9):84. PubMed ID: 34302549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-COVID highlights: Challenges and solutions of artificial intelligence techniques for swift identification of COVID-19.
    Fang Y; Xing X; Wang S; Walsh S; Yang G
    Curr Opin Struct Biol; 2024 Apr; 85():102778. PubMed ID: 38364679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming Public Health Practice With Generative Artificial Intelligence.
    Bharel M; Auerbach J; Nguyen V; DeSalvo KB
    Health Aff (Millwood); 2024 Jun; 43(6):776-782. PubMed ID: 38830160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging technologies for combating pandemics.
    Weaver E; Uddin S; Lamprou DA
    Expert Rev Med Devices; 2022 Jul; 19(7):533-538. PubMed ID: 35983986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrochemical SARS-CoV-2 Sensing at Point-of-Care and Artificial Intelligence for Intelligent COVID-19 Management.
    Kaushik AK; Dhau JS; Gohel H; Mishra YK; Kateb B; Kim NY; Goswami DY
    ACS Appl Bio Mater; 2020 Nov; 3(11):7306-7325. PubMed ID: 35019473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology-Enabled and Artificial Intelligence Support for Pre-Visit Planning in Ambulatory Care: Findings From an Environmental Scan.
    Holdsworth LM; Park C; Asch SM; Lin S
    Ann Fam Med; 2021; 19(5):419-426. PubMed ID: 34546948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Pandemic and SMEs Performance Decline: The Mediating Role of Management Innovation and Organizational Resilience.
    Li Y; Chen H; Wei L; Wei L
    Front Public Health; 2022; 10():944742. PubMed ID: 35903388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Digital Health Innovation Policy: A Portal to Alternative Futures in the Making.
    Bayram M; Springer S; Garvey CK; Özdemir V
    OMICS; 2020 Aug; 24(8):460-469. PubMed ID: 32511054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Intelligence and Reduced SMEs' Business Risks. A Dynamic Capabilities Analysis During the COVID-19 Pandemic.
    Drydakis N
    Inf Syst Front; 2022; 24(4):1223-1247. PubMed ID: 35261558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness.
    Parums DV
    Med Sci Monit; 2023 Jun; 29():e941209. PubMed ID: 37259578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing artificial intelligence in the post-COVID-19 era: A global health imperative.
    Gulumbe BH; Yusuf ZM; Hashim AM
    Trop Doct; 2023 Oct; 53(4):414-415. PubMed ID: 37340738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Innovative Community Care and the Sustainable Development of University Social Responsibility in the Post-Pandemic Era].
    Huang CL
    Hu Li Za Zhi; 2022 Jun; 69(3):4-6. PubMed ID: 35644590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital Transformation of Public Health for Noncommunicable Diseases: Narrative Viewpoint of Challenges and Opportunities.
    Leal Neto O; Von Wyl V
    JMIR Public Health Surveill; 2024 Jan; 10():e49575. PubMed ID: 38271097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.